» Articles » PMID: 36498810

Starting Home Telemonitoring and Oxygen Therapy Directly After Emergency Department Assessment Appears to Be Safe in COVID-19 Patients

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Dec 11
PMID 36498810
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since data on the safety and effectiveness of home telemonitoring and oxygen therapy started directly after Emergency Department (ED) assessment in COVID-19 patients are sparse but could have many advantages, we evaluated these parameters in this study.

Methods: All COVID-19 patients ≥18 years eligible for receiving home telemonitoring (November 2020-February 2022, Albert Schweitzer hospital, the Netherlands) were included: patients started directly after ED assessment (ED group) or after hospital admission (admission group). Safety (number of ED reassessments and hospital readmissions) and effectiveness (number of phone calls, duration of oxygen usage and home telemonitoring) were described in both groups.

Results: 278 patients were included ( = 65 ED group, = 213 admission group). ED group: 23.8% ( = 15) was reassessed, 15.9% ( = 10) was admitted and 7.7% ( = 5) ICU admitted. Admission group: 15.8% ( = 37) was reassessed, 6.5% ( = 14) was readmitted and 2.4% ( = 5) ICU (re)admitted. Ten patients died, of whom 7 due to COVID-19 (1 in ED group; 6 in the admission group). ED group: median duration of oxygen therapy was 9 (IQR 7-13) days; the total duration of home telemonitoring was 14 (IQR 9-18) days. Admission group: duration of oxygen therapy was 10 (IQR 6-16) days; total duration of home telemonitoring was 14 (IQR 10-20) days.

Conclusion: it appears to be safe to start home telemonitoring and oxygen therapy directly after ED assessment.

Citing Articles

2023 Year in Review: Home Oxygen Therapy.

Wiles K Respir Care. 2024; 69(9):1182-1188.

PMID: 39181721 PMC: 11349592. DOI: 10.4187/respcare.12070.


Early Hospital Discharge Using Remote Monitoring for Patients Hospitalized for COVID-19, Regardless of Need for Home Oxygen Therapy: A Descriptive Study.

Talha S, Lamrous S, Kassegne L, Lefebvre N, Zulfiqar A, Tran Ba Loc P J Clin Med. 2023; 12(15).

PMID: 37568502 PMC: 10419442. DOI: 10.3390/jcm12155100.


Home oxygen therapy from the emergency department for COVID-19 an observational study.

Schoenling A, Frisch A, Callaway C, Yealy D, Weissman A Am J Emerg Med. 2023; 68:47-51.

PMID: 36933333 PMC: 9993732. DOI: 10.1016/j.ajem.2023.03.012.

References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

2.
Steel P, Siegal J, Zhang Y, Cato K, Greenwald P, Melville L . Telehealth follow up in emergency department patients discharged with COVID-like illness and exertional hypoxia. Am J Emerg Med. 2021; 49:426-430. PMC: 7919584. DOI: 10.1016/j.ajem.2021.02.052. View

3.
van Herwerden M, van Steenkiste J, El Moussaoui R, den Hollander J, Helfrich G, J A M Verberk I . [Home telemonitoring and oxygen therapy in COVID-19 patients: safety, patient satisfaction, and cost-effectiveness]. Ned Tijdschr Geneeskd. 2021; 165. View

4.
Banerjee J, Canamar C, Voyageur C, Tangpraphaphorn S, Lemus A, Coffey Jr C . Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen. JAMA Netw Open. 2021; 4(4):e213990. PMC: 8017465. DOI: 10.1001/jamanetworkopen.2021.3990. View

5.
Gruwez H, Bakelants E, Dreesen P, Broekmans J, Criel M, Thomeer M . Remote patient monitoring in COVID-19: a critical appraisal. Eur Respir J. 2022; 59(2). PMC: 8812467. DOI: 10.1183/13993003.02697-2021. View